People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Pharmaceuticals, Other, Biotechnology, Other Technology, Fintech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AEON Biopharma, Inc. | — | Pharmaceuticals | Series C | $197.1M | $511.8M | 2020 |
| Myoscience, Inc | — | Other | Series B | $122.6M | $83.1M | 2012 |
| Alphaeon 1 LLC | — | Other | Series C | $96.8M | $1.7B | 2020 |
| Reshape Medical, Inc. | — | Biotechnology | Series B | $75.1M | $436.6M | 2012 |
| Nanoscale Components, Inc. | — | Other Technology | Series A | $27.1M | $249.6M | 2012 |
| Alphaeon Credit HoldCo LLC | — | Fintech | Series B | $19.5M | $560.9M | 2020 |
| Zelegent HoldCo LLC | — | Other | Series A | $8.7M | $121.4M | 2020 |
| Flyreel, Inc. | — | Other | Series A | $8.3M | $32.5M | 2019 |
| Zelegent, Inc. | — | Other Health Care | Seed | $3.1M | $3.5M | 2018 |
| Eagle Technologies, Inc. | — | Other | Pre-Seed | $1.0M | $23.1M | 2009 |
| FieldTek, Inc | — | Other Technology | Pre-Seed | $875K | $37.1M | 2016 |
| Start Lighting, Inc. | — | Other | Pre-Seed | $530K | $6.9M | 2015 |
Robert Grant at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Grant on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Vikram Malik | 4 | 5 |
| Simone Blank | 4 | 5 |
| Jost Fischer | 4 | 4 |
| Darren O'Brien | 4 | 4 |
| Robert Hawk | 3 | 9 |
| RICK TAKETA | 3 | 3 |
| DAVID MEREDITH | 2 | 3 |
| Richard Thompson | 1 | 17 |
| Richard Ferrari | 1 | 15 |
| Casey Tansey | 1 | 14 |
| Bruce Feuchter | 1 | 12 |
| Yuri Pikover | 1 | 9 |
| George Wallace | 1 | 8 |
| Jeani Delagardelle | 1 | 8 |
| David Milne | 1 | 7 |
| John Preston | 1 | 7 |
| Bosun Hau | 1 | 6 |
| Anthony Lando | 1 | 6 |
| David Schroeder | 1 | 5 |
| Richard M. Ferrari | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.